Infectious Diseases 1210 - Infectious Disease Alert - Oct 01, 2008

Target Audience:

This activity is intended for the infectious disease specialist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editors
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Stanford
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewers
Connie Price, MD
Assistant Professor
University of Colorado School of Medicine

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center
Section Editor, Updates
Section Editor, HIV

Associate Editors
Robert Muder, MD
Hospital Epidemiologist
Pittsburgh VA Medical Center

Jessica C. Song, MA, PharmD
Associate Professor
Pharmacy Practice
University of the Pacific
Stockton, CA

Authors
Brian Blackburn, MD
Clinical Assistant Professor of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine

Catherine J. Hill, PharmD
PGY1 Pharmacy Resident, Santa Clara Valley Medical Center, San Jose, CA.

Subjects:

  • Chronically Infected Patients with Trypanosoma cruzi Parasitemia: Further Support for Screening
  • CMV Reactivation/Outcome in Critically Ill Patients
  • Pregnancy Counseling in HIV
  • Prevention of Influenza: 2008-2009
  • Pharmacokinetics of Antimicrobials in Patients with Burn Wounds
  • Updates

Objectives:

  • discuss the diagnosis and treatment of infectious diseases
  • present current data regarding the use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • present the latest information regarding the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • discuss new information regarding how infectious diseases (eg, AIDS) are transmitted and how such information can lead to the development of new therapy

Financial Disclosure:

Infectious Disease Alert's Physician Editor, Stan Deresinski, MD, FACP, serves on the speaker's bureau of Merck, Pharmacia, GlaxoSmithKline, Pfizer, Bayer, and Wyeth, and does research for Merck.

Peer Reviewer Connie Price, MD, reports no consultant, stockholder, speaker's bureau, research, or other financial relationship with any company related to this field of study.

Updates author Carol A. Kemper, MD, FACP, Authors Brian Blackburn, MD, and Catherine J. Hill, PharmD, Associate Editor Jessica C. Song, MA, PharmD, report no financial relationships relevant to this field of study.

Associate Editor Robert Muder, MD, does research for Aventis and Pharmacia.

Copyright 2008 AHC Media. All rights reserved.